Search by CAS No , Chemical Name or Molecular Formula
Long Term Storage
"Leuprorelin, also known as leuprolide, is a manufactured version of a hormone used to treat prostate cancer, breast cancer, endometriosis, uterine fibroids, and early puberty. It is given by injection into a muscle or under the skin.
Common side effects include hot flashes, unstable mood, trouble sleeping, headaches, and pain at the site of injection. Other side effects may include high blood sugar, allergic reactions, and problems with the pituitary gland. Use during pregnancy may harm the baby. Leuprorelin is in the gonadotropin-releasing hormone (GnRH) analogue family of medication. It works by decreasing gonadotropin and therefore decreasing testosterone and estradiol.
Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD. It is sold under the brand name Lupron among others.",""
Labeled Leuprorelin, intended for use as an internal standard for the quantification of Leuprorelin by GC- or LC-mass spectrometry.
Doraiswamy PM, Xiong GL. (2006); Crosignani PG, Luciano A, Ray A, Bergqvist A (January 2006
We normally respond within 8 hours.
This page contains information about Leuprorelin D10 Cas # 53714-56-0 (Unlabeled) and its Stable Isotopes.
Leuprorelin D10 Leuprorelin D10 Worldwide Suppliers of Leuprorelin D10 https://www.clearsynth.com/en/CSO03186.html Stable Isotopes Clearsynth 53714-56-0 (Unlabeled)
Product rating: 9 Leuprorelin D10 based on 20 ratings
Keywords: Leuprorelin D10, CS-O-03186, 53714-56-0 (Unlabeled), 1-(3-((1H-imidazol-5-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-((diaminomethylene)amino)propyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl D10-1,4,7,10,13,16,19-heptaoxo-1-(5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaaate, C59H74D10N16O12 ·CHCO2H , 1279.51, Labeled Leuprorelin, intended for use as an internal standard for the quantification of Leuprorelin by GC- or LC-mass spectrometry.
Internal standard, Internal standard Leuprorelin, HPLC-MS method validation, HPLC-MS method validation Leuprorelin, LC-MS-MS method validation, LC-MS-MS method validation Leuprorelin, Deuterated internal standard, Deuterated internal standard Leuprorelin, Deuterated Leuprorelin, Deuterium labeled Leuprorelin, Quantitative bioanalytical methods, Quantitative bioanalytical methods Leuprorelin, Blood samples Leuprorelin, Blood concentrations, Heavy drugs, Analysis, Analysis Leuprorelin, Clinical diagnostic, Clinical diagnostic Leuprorelin, Dosing Leuprorelin, Analytical method development, Internal standard method.
CLEARSYNTH CANADA INC.
2395 Speakman Drive,
Lab: 1001, Mississauga, ON,
Canada L5K 1B3
T : +1-289-729-0060
CLEARSYNTH RESEARCH CENTRE
Plot No. 177, IDA, Mallapur,
T : +91-40-27155481
CLEARSYNTH LABS LTD
17, Lotus Business Park,
Andheri (W), Mumbai - 400053
T : +91-22-45045945